SUSMED,Inc. (TYO:4263)

SUSMED,Inc. Statistics

Total Valuation

SUSMED,Inc. has a market cap or net worth of JPY 14.93 billion. The enterprise value is 10.76 billion.

Market Cap	14.93B
Enterprise Value	10.76B

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

SUSMED,Inc. has 16.81 million shares outstanding. The number of shares has increased by 0.50% in one year.

Current Share Class	16.81M
Shares Outstanding	16.81M
Shares Change (YoY)	+0.50%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	42.64%
Owned by Institutions (%)	8.81%
Float	7.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.43
PB Ratio	3.51
P/TBV Ratio	3.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-42.21
EV / Sales	22.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 35.09

Current Ratio	35.09
Quick Ratio	34.56
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -5.86% and return on invested capital (ROIC) is -3.89%.

Return on Equity (ROE)	-5.86%
Return on Assets (ROA)	-3.70%
Return on Invested Capital (ROIC)	-3.89%
Return on Capital Employed (ROCE)	-6.37%
Revenue Per Employee	11.05M
Profits Per Employee	-5.93M
Employee Count	43
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

In the past 12 months, SUSMED,Inc. has paid 1.00 million in taxes.

Income Tax	1.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.49% in the last 52 weeks. The beta is 1.32, so SUSMED,Inc.'s price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	+57.49%
50-Day Moving Average	891.20
200-Day Moving Average	698.64
Relative Strength Index (RSI)	52.55
Average Volume (20 Days)	149,830

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SUSMED,Inc. had revenue of JPY 475.00 million and -255.00 million in losses. Loss per share was -15.17.

Revenue	475.00M
Gross Profit	461.00M
Operating Income	-271.00M
Pretax Income	-254.00M
Net Income	-255.00M
EBITDA	-263.50M
EBIT	-271.00M
Loss Per Share	-15.17

Balance Sheet

The company has 4.17 billion in cash and n/a in debt, giving a net cash position of 4.17 billion or 247.85 per share.

Cash & Cash Equivalents	4.17B
Total Debt	n/a
Net Cash	4.17B
Net Cash Per Share	247.85
Equity (Book Value)	4.25B
Book Value Per Share	252.97
Working Capital	4.13B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 97.05%, with operating and profit margins of -57.05% and -53.68%.

Gross Margin	97.05%
Operating Margin	-57.05%
Pretax Margin	-53.47%
Profit Margin	-53.68%
EBITDA Margin	-55.47%
EBIT Margin	-57.05%
FCF Margin	n/a

Dividends & Yields

SUSMED,Inc. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.50%
Shareholder Yield	-0.50%
Earnings Yield	-1.71%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SUSMED,Inc. has an Altman Z-Score of 54.04 and a Piotroski F-Score of 2.

Altman Z-Score	54.04
Piotroski F-Score	2